Request Deal Involvement

Boyu Capital, Matrix Partners China, Sequoia Capital China, Temasek, and WuXi AppTec led a $200m Series A round in D3 Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

LaVoieHealthScience

pr advisors

LaVoieHealthScience

or

Principals

BOYU CAPITAL

bidder

BOYU CAPITAL

WUXI APPTEC

bidder

WUXI APPTEC

TEMASEK HOLDINGS LIMITED

bidder

TEMASEK HOLDINGS LIMITED

MATRIX PARTNERS

bidder

MATRIX PARTNERS

SEQUOIA CAPITAL

bidder

SEQUOIA CAPITAL

D3 BIO

target

D3 BIO

GE LI

bidder

GE LI

NING ZHAO

bidder

NING ZHAO

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Boyu Capital, Matrix Partners China, Sequoia Capital China, Temasek, and WuXi AppTec led a $200m Series A round in D3 Bio.